Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Capillary Zone Electrophoresis Developed for Rapid Determination of Thalassemia

By LabMedica International staff writers
Posted on 10 Jun 2015
A capillary zone electrophoresis (CZE) method has been developed for human globin determination in the diagnosis of thalassemia and hemoglobin variants as analysis of globin chains is an important aspect of thalassemia diagnostics. More...


Thalassemia is an inherited autosomal recessive blood disorder characterized by the underproduction of globin chains as a consequence of globin gene defects, resulting in malfunctioning red blood cells and oxygen transport.

Medical scientists at the Southern Medical University (Guangzhou, China) evaluated an assay on blood samples obtained from anticoagulated whole blood from a total of 310 clinical samples consisting of 58 normal, 107 α-thalassemia silent/trait, 42 β-thalassemia carriers and 63 β-thalassemia major and β-thalassemia intermedia (β -TM/TI), and 40 others with various hemoglobinopathies.

Hemoglobin analysis was carried out using the high-performance liquid chromatography (HPLC, Variant II, Bio-Rad Laboratories; Hercules, CA, USA). Capillary zone electrophoresis (CZE) was performed using a P/ACE MDQ Capillary Electrophoresis System (Beckman Coulter Inc.; Fullerton, CA, USA) equipped with a 70 cm × 50 μm uncoated fused-silica capillary at 25 °C.

Distinct globin peaks were resolved in 17 minutes and coefficients of variation (CV) for migration time and areas ranged from 0.37% to 1.69% and 0.46% to 6.71%, respectively. Receiver operating characteristic (ROC) curve analysis of the α/β area ratios gave 100% sensitivity and specificity for indicating β-TI/TM, and 100% sensitivity and 97.4% specificity for Hb H disease. Hemoglobin G-Honolulu (Hb G-Honolulu) and Hb Westmead (Hb WS) were successfully detected using this CZE method.

The authors concluded that they had successfully developed a simple, rapid, high-resolution CZE method for the separation of globin chains using highly acidic buffer and uncoated capillaries. Using this method, α-, β- and γ-chains, and αWS and αG Honolulu  chains were successfully separated within 17 minutes, indicating suitability for routine clinical applications. The migration times and globin chain peak areas were highly reproducible; although not as rapid as existing high-throughput HPLC techniques. This CZE method may provide an attractive complementary and/or confirmatory approach. The study was published in the June 2015 issue of the journal Blood Cells Molecules and Diseases.

Related Links:

Southern Medical University 
Bio-Rad Laboratories  
Beckman Coulter Inc.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automatic CLIA Analyzer
Shine i6000
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Blood Protein Analysis Reveals Menopause-Associated Signals of Brain Aging

Menopause affects women across midlife and is often accompanied by endocrine changes, hot flashes, brain fog and sleep disturbances. Women spend roughly one third of their lives after the menopause transition,... Read more

Molecular Diagnostics

view channel
Image: These images show breast tumors in a new preclinical model developed by Garvan researchers. The cells carry a fluorescent sensor that lights up blue/green when CDK1—the protein \'engine\' cells need to divide—is switched on. Using it, the team watched CDK1 activity rise as tumors became invasive and stay high in tumors that kept growing despite treatment. (Image Credit: Dr. Max Nobis / Garvan Institute)

Study Finds Potential Marker of Targeted Drug Resistance in Breast Cancer

Estrogen receptor-positive breast cancer is the most common breast cancer subtype and is driven by estrogen. Many patients are treated with CDK4/6 inhibitors alongside hormone therapy, but these drugs... Read more

Microbiology

view channel
Image: Four-quadrant streaking of fecal samples on chromogenic UTI agar shows various patterns of relative bacterial species abundance. The assorted shapes of the pinkish colonies indicate different E. coli strains. (Photo courtesy of Sokurenko Lab)

Stool Testing Predicts UTI Risk and Guides Antibiotic Selection

Urinary tract infections (UTIs) are a common reason for antibiotic prescribing in general medical practice and can be painful in postmenopausal women, sometimes progressing to kidney infection or life-threatening... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The ExaccType ESR1 dPCR Kit uses digital PCR technology to detect key ESR1 mutations associated with acquired resistance to endocrine therapy. (Photo courtesy of  BIOTYPE)

Collaboration Expands Access to Tests for Cancer Treatment Resistance and Toxicity Risk

Precision medicine in oncology relies on molecular testing to identify biomarkers that can help guide treatment decisions. In hormone receptor-positive, HER2-negative metastatic breast cancer, ESR1 mutations... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.